FDA Posts Investigator In Singapore, But Trims Foreign Office List
This article was originally published in The Tan Sheet
Executive Summary
FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA shifts away from primarily a domestic focus to global as drug criminal organizations spread globally